Skip Navigation

Vitamin D & Health in the 21st Century Agenda

Skip sharing on social media links

Conference Invitation


Travel Award Announcement

Faculty List

Thursday, October 9, 2003

8:30- 9:00 Introduction/Convocation
Session I: Overview of Vitamin D (25 minute talks with 5 minute Q & A)
9:00-9:30 Historical Overview of Vitamin D from a Public Health Perspective
Speaker: Mike Holick, Boston University
9:30-10:00 Vitamin D Biology: Overview General Physiology, and Function of Vitamin D
Speaker: Hector Deluca, University of Wisconsin-Madison
10:00-10:30 Vitamin D: A Global Perspective
Speaker: Gerald Combs, USDA/ARS/HNRCGF
10:30-11:00 BREAK
Session 2: Epidemiology, Demographics and Methodologies (20 Minute Talks-10 Minute Q & A)
Session Chair: Anne Looker, NCHS/CDC
11:00-11:30 Current Data on Prevalence in the United States: Age and Racial Risk Groups
Speaker: Kelley Scanlon, CDC
11:30-12:00 Vitamin D Assessment: A Global Perspective of Needs and Current Concerns
Speaker: Christel Lamberg-Allardt, University of Helsinki, Finland
12:00-12:30 Biomarkers: Functional Indices of Vitamin D Status and Functional Ramifications of Marginal or Deficient Status
Speaker: Robert Heaney, Creighton University
12:30-1:00 Vitamin D Fortification: Data Needs and Current Status
Speaker: Mona Calvo, FDA
1:00-2:00 LUNCH
2:00-2:30 Panel Discussion 1: Questions
  1. What are five research priorities?
  2. What are the major needs with regard to methodologies?
Session 3: Current Understanding of the Role of Vitamin D in Health and Potential Mechanisms for Vitamin D-Related Disease (20 Minute Talks-10 Minute Q & A)
Session Chair: Gerald Combs, USDA/ARS/HNRCGF
2:30-3:00 Overview of Potential Association between Vitamin D, UV Exposure, and Disease
Speaker: William B. Grant, Newport News, VA
3:00-3:30 Vitamin D and the Immune System
Speaker: Margherita Cantorna, Penn State University
3:30-4:00 Vitamin D and Cancer: Case Study of Vitamin D and Breast Cancer
Speaker: JoEllen Welsh, Notre Dame University
4:00-4:30 Nutritional Rickets: Vitamin D, Calcium, or Both?
Speaker: John Pettifor, University of Witwatersand, South Africa
4:30-4:45 BREAK
4:45-5:15 New Methodologies for Probing the Role(s) of Vitamin D in Health
Speaker: Jim Fleet, Purdue University
5:15-5:45 Panel Discussion 2: Questions
  1. What are the five priority areas in the vitamin D/disease relationship?
  2. What are the current obstacles (e.g., methodologies) for the exploration of the vitamin D/health relationship?
  3. What is the best approach to addressing vitamin D and health in the international setting?
6:00-9:00 Conference Reception: Bethesda Marriott Hotel, 5151 Pooks Hill Road

Friday, October 10, 2003

Session 4: Developmental, Ethnic/Racial Considerations in Generating Recommendations for Vitamin D (20-Minute Talks-10 Minute Q & A)
Session Chair: TBA
9:00-9:30 Overview of Current Vitamin D Recommendations
Speaker: Connie Weaver, Purdue University
9:30-10:00 Pregnancy
Speaker: Bonnie Specker, South Dakota State University
10:00-10:30 Prenatal/Fetal and Infant Predictors of Bone Health
Speaker: Nicolas Bishop, University of Sheffield
10:30-11:00 BREAK
11:00-11:30 Lactation
Speaker: Bruce Hollis, Medical University of South Carolina
11:30-12:00 Issues in Establishing Recommendations for Infants and Children
Speaker: Frank Greer, Meriter Hospital, Madison, WI
12:00-12:30 Adults/Elderly
Speaker: Bess Dawson-Hughes, Tufts University
12:30-1:30 LUNCH
1:30-2:30 Panel Discussion 3: Questions
  1. Are the current dietary recommendations for vitamin D adequate?
  2. What are the research priorities: data needs to set meaningful recommendations for different developmental and/or racial/ethnic groups?
  3. Given the current state of knowledge what are the public health approaches to achieve vitamin D adequacy?
  4. What factors need to be considered with regard to amount, duration, and target groups for dietary or other (UV exposure) interventions/recommendations?
  5. How can we account for potential confluence of health messages to create adverse outcomes (UV protection vs. vitamin D adequacy)?
  6. Is there a need for special considerations for health disparities?
Session 5: Conclusions/Recommendations: Summary Discussion
Panel: session chairs, organizers, representatives from sponsoring agencies
2:30- 3:00 Questions:
  1. What are key research/program priorities?
  2. What are the key program priorities for your agency/program?
  3. How best to coordinate agency/organization response to current data needs/public health issues?
Last Reviewed: 11/30/2012
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology